Prof. Steve Jackson of the Wellcome Trust/ Cancer Research UK Gurdon Institute, University of Cambridge, has won the 2016 Dr A. H. Heineken Prize for Medicine, for "his fundamental research into DNA repair in human cells and for the successful application of knowledge of that process in the development of new cancer drugs".
Tumours kill off surrounding cells to make room to grow, according to new research from the University of Cambridge. Although the study was carried out using fruit flies, its findings suggest that drugs to prevent, rather than encourage, cell death might be effective at fighting cancer – contrary to how many of the current chemotherapy drugs work.
The world of epigenetics – where molecular ‘switches’ attached to DNA turn genes on and off – has just got bigger with the discovery by a team of scientists from the University of Cambridge of a new type of epigenetic modification.
Azim Surani (Wellcome Trust/Cancer Research UK Gurdon Institute) discusses gene editing of the human germline.
Professor Steve Jackson, Head of Cancer Research UK Labs and Senior Group Leader at the Gurdon Institute, University of Cambridge, has been awarded the Gagna A. & Ch. Van Heck Prize 2015 in Belgium, "for his cardinal contributions related to cellular events that detect, signal the presence of and repair DNA damages".
The journey from a single fertilised egg cell through to a baby delivered crying into the arms of its mother is one of the most beautiful and complex processes to occur in nature. We are only just beginning to understand the very earliest stages of life – when we are nothing more than a cluster of cells.
Cambridge researchers and pharma in innovative new consortium to develop and study early stage drugs28 Jul 2015
An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.